Meda Pharmaceuticals Inc
General
Total Cases28
Active Cases4
Patents37
Ratings
Experience
Grade
Trend
DCT
L5
D
PTAB
L5
A
CAFC
L5
A
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 05/23/24 | Report to the Commissioner of Patents and Trademarks. (lnb) (Entered: 05/23/2024) | |
| 05/23/24 | SO ORDERED, re 8 Stipulation of Dismissal filed by Meda Pharmaceuticals Inc., Bayer HealthCare LLC, ***Civil Case Terminated. Signed by Judge Gregory B. Williams on 5/23/2024. (lnb) (Entered: 05/23/2024) | |
| 05/22/24 | STIPULATION of Dismissal (without prejudice) - by Bayer HealthCare LLC, Meda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 05/22/2024) | |
| 04/03/24 | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 04/03/2024) | |
| 03/29/24 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Viatris Inc. for Meda Pharmaceuticals Inc. filed by Meda Pharmaceuticals Inc.. (Cordo, Andrew) (Entered: 03/29/2024) | |
| 03/28/24 | Summonses Issued as to Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. on 3/28/2024. (Attachments: # 1 Summons Issued Aurobindo Pharma USA, Inc.)(jfm) (Entered: 03/28/2024) | |
| 03/28/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer HealthCare LLC filed by Bayer HealthCare LLC. (jfm) (Entered: 03/28/2024) | |
| 03/28/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,071,073 B2; 8,518,919 B2; 9,919,050 B2. (jfm) (Entered: 03/28/2024) | |
| 03/28/24 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/14/2024. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 8/14/2026. (jfm) (Entered: 03/28/2024) | |
| 03/28/24 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 03/28/2024) |